|
Volumn 38, Issue 5, 2011, Pages 613-616
|
Review of new clinical applications of radiometal labeled radiopharmaceuticals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS IMAGING AGENT;
ARGINYLGLYCYLASPARTIC ACID;
CONTRAST MEDIUM;
FLORBETABEN;
FLUCICLATIDE F 18;
FLUCICLOVINE F 18;
FLUORINE 18;
FLUTEMETAMOL F 18;
GALLIUM 68;
IODINE;
LYMPHOSEEK;
MARACICLATIDE TC 99M;
MIP 1340 TC 99M;
RADIOPHARMACEUTICAL AGENT;
RECEPTOR;
TECHNETIUM 99M;
TRACER;
TROFEX;
UNCLASSIFIED DRUG;
CANCER DIAGNOSIS;
CLINICAL MEDICINE;
DIAGNOSTIC IMAGING;
DRUG INDUSTRY;
DRUG RESEARCH;
ECONOMIC ASPECT;
HUMAN;
INTRAOPERATIVE LYMPHATIC MAPPING;
INTRAOPERATIVE PERIOD;
LYMPHATIC SYSTEM EXAMINATION;
ONCOLOGY;
POSITRON EMISSION TOMOGRAPHY;
PROSTATE CANCER;
REVIEW;
SOLID TUMOR;
CLINICAL MEDICINE;
HUMANS;
ISOTOPE LABELING;
METALS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
RADIOPHARMACEUTICALS;
|
EID: 79959634939
PISSN: 09698051
EISSN: 18729614
Source Type: Journal
DOI: 10.1016/j.nucmedbio.2010.12.009 Document Type: Review |
Times cited : (9)
|
References (0)
|